[go: up one dir, main page]

AU2003269481A1 - (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt - Google Patents

(s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt

Info

Publication number
AU2003269481A1
AU2003269481A1 AU2003269481A AU2003269481A AU2003269481A1 AU 2003269481 A1 AU2003269481 A1 AU 2003269481A1 AU 2003269481 A AU2003269481 A AU 2003269481A AU 2003269481 A AU2003269481 A AU 2003269481A AU 2003269481 A1 AU2003269481 A1 AU 2003269481A1
Authority
AU
Australia
Prior art keywords
methyl
butylcarbamoyl
piperidin
ethoxy
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269481A
Other languages
English (en)
Inventor
Sambasivam Ganesh
Joy Mathew
Tom Thomas Puthiaparampil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biocon Ltd
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of AU2003269481A1 publication Critical patent/AU2003269481A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003269481A 2003-09-10 2003-09-10 (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt Abandoned AU2003269481A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2003/000304 WO2005023790A1 (fr) 2003-09-10 2003-09-10 Sel sodique d'acide (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoique

Publications (1)

Publication Number Publication Date
AU2003269481A1 true AU2003269481A1 (en) 2005-03-29

Family

ID=34259919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269481A Abandoned AU2003269481A1 (en) 2003-09-10 2003-09-10 (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt

Country Status (2)

Country Link
AU (1) AU2003269481A1 (fr)
WO (1) WO2005023790A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735959A (en) * 1981-01-10 1988-04-05 Dr. Karl Thomae Gmbh Carboxylic acid amides and pharmaceutical compositions containing them
DE3320582A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Gliquidonhaltige zubereitungsformen und verfahren zu ihrer herstellung
US5216167A (en) * 1983-12-30 1993-06-01 Dr. Karl Thomae Gmbh Phenylacetic acid benzylamides
US5312924A (en) * 1983-12-30 1994-05-17 Dr. Karl Thomae Gmbh Phenylacetic acid benzylamides

Also Published As

Publication number Publication date
WO2005023790A1 (fr) 2005-03-17

Similar Documents

Publication Publication Date Title
AU2003290734A1 (en) Novel compounds as pharmaceutical agents
AU2003296419A1 (en) Pyrenyloxysulfonic acid fluorescent agents
EP1583537A3 (fr) Composés de piperidine comme antibactérien
AU2003248259A1 (en) Novel azetidine derivative or salt thereof
AU2003211131A1 (en) Metformin salts of lipophilic acids
AU2003214112A1 (en) Salts of nateglinide
AU2003226751A1 (en) Low water-soluble venlafaxine salts
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2003216853A1 (en) Improvements relating to information delivery
AU2003216053A1 (en) Guanidino compounds
AU2003289171A1 (en) Cosmetic preparation containing glycerylamino acid derivative
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003268288A1 (en) Nosebleed lip pack
AU2003291642A1 (en) Pyrazoloazepine compounds as pharmaceutical agents
AU2003247578A1 (en) Compound for flex sole
AU2003298207A1 (en) Aqueous acaricidal solution
AU2003269481A1 (en) (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid sodium salt
AU2003249491A1 (en) Hyaluronic acid derivatives
EP1632476A4 (fr) Sel d'addition d'acide de derive d'amine de carbasucre
AU2003265090A1 (en) Antimicrobial 1-aryl dihydropyridone compounds
AU2003251523A1 (en) Processes for making (r)-ethyl 4-cyano-3-hydroxybutyric acid
AU2003269480A1 (en) Phosphoric acid salt of (s)-(+)-2-ethoxy-4-{(3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl)-methyl}-benzoic acid
AU2003235429A1 (en) (2s)-2-ethylphenylpropionic acid derivative
AU2002246303A1 (en) Preparation of new mineral acid addition salts of gabapentin
AU2003302645A1 (en) Synthesis of pyrrolidine compound and salt thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase